Allogeneic hematopoietic stem cell transplantation (aHSCT) is an important modality for treating hematologic malignancies as well as many non-malignant conditions in children and young adults. Pulmonary complications are relatively common after pediatric aHSCT and cause significant morbidity and mortality...
In kidney transplant recipients, reactivation of BK polyomavirus (BKPyV) replication is a common consequence of immunosuppressive therapy, which can progress to BKPyV-associated nephropathy (BKPyVAN), and ultimately to graft loss [1]. Additionally, primary BKPyV infection can occur in BKPyV-naïve...
The multifaceted demands of pediatric kidney transplant care are well recognized. To optimize outcomes of pediatric kidney transplant recipients, the American Society of Pediatric Nephrology recommends delivering care through a multidisciplinary paradigm [1], which often encompasses a pediatric nephrologist,...
Despite advances in immunosuppressive therapies, development of acute allograft rejection remains a common complication in pediatric and adolescent kidney transplant recipients (KTR). Predisposing risk factors for development of acute rejection are multifactorial and can include inadequate immunosuppression,...
Pediatric kidney transplant recipients are known to experience a heightened risk for cardiovascular (CV) disease [1]. Obesity and metabolic syndrome are highly prevalent among transplant recipients and are key factors that accelerate the process of arterial stiffening, further contributing to increased...